[go: up one dir, main page]

PL346346A1 - Cyclic prosaposin-derived peptides and uses thereof - Google Patents

Cyclic prosaposin-derived peptides and uses thereof

Info

Publication number
PL346346A1
PL346346A1 PL99346346A PL34634699A PL346346A1 PL 346346 A1 PL346346 A1 PL 346346A1 PL 99346346 A PL99346346 A PL 99346346A PL 34634699 A PL34634699 A PL 34634699A PL 346346 A1 PL346346 A1 PL 346346A1
Authority
PL
Poland
Prior art keywords
derived peptides
prosaposin
cyclic
cyclic prosaposin
peptides
Prior art date
Application number
PL99346346A
Other versions
PL204359B1 (en
Inventor
David E Wright
John S O'brien
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of PL346346A1 publication Critical patent/PL346346A1/en
Publication of PL204359B1 publication Critical patent/PL204359B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL346346A 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof PL204359B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28

Publications (2)

Publication Number Publication Date
PL346346A1 true PL346346A1 (en) 2002-02-11
PL204359B1 PL204359B1 (en) 2010-01-29

Family

ID=22268937

Family Applications (1)

Application Number Title Priority Date Filing Date
PL346346A PL204359B1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Country Status (13)

Country Link
EP (1) EP1105420A1 (en)
JP (2) JP4528443B2 (en)
KR (1) KR20010079695A (en)
CN (1) CN1324367A (en)
AU (1) AU751034B2 (en)
BR (1) BR9913490A (en)
CA (1) CA2341810A1 (en)
CZ (1) CZ2001655A3 (en)
HU (1) HUP0103265A3 (en)
IL (1) IL141586A0 (en)
PL (1) PL204359B1 (en)
WO (1) WO2000012553A1 (en)
ZA (1) ZA200102489B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
AU751034B2 (en) * 1998-08-28 2002-08-08 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (en) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS: A new anticancer drug
EP3357490A1 (en) 2006-04-28 2018-08-08 Children's Hospital Medical Center Fusogenic properties of saposin c and related proteins and polypeptides for application to transmembrane drug delivery systems
WO2008051818A2 (en) * 2006-10-20 2008-05-02 Children's Hospital Medical Center Spontaneously forming ellipsoidal phospholipid unilamellar vesicles
CN103275187B (en) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 Analgesic peptide FI as well as genes and application thereof
US11291616B2 (en) 2015-04-23 2022-04-05 The Procter And Gamble Company Delivery of surfactant soluble anti-dandruff agent
BR112018067494B1 (en) 2016-03-03 2022-05-10 The Procter & Gamble Company Aerosol anti-dandruff composition
CN109843381A (en) 2016-10-21 2019-06-04 宝洁公司 Concentrated shampoo foam formulation for providing hair care benefits
CN109789076A (en) 2016-10-21 2019-05-21 宝洁公司 Stable fine and close shampoo product with low viscosity and viscosity reducers
CN109862944A (en) 2016-10-21 2019-06-07 宝洁公司 Foam dosage forms for delivering the dosage form volume and surfactant dosage required by the consumer in an optimal formulation space
CN109843252A (en) 2016-10-21 2019-06-04 宝洁公司 The concentrated type shampoo foam of specified hair volume beneficial effect
WO2018075836A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
WO2018075855A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
US11154467B2 (en) 2016-10-21 2021-10-26 The Procter And Gamble Plaza Concentrated shampoo dosage of foam designating hair conditioning benefits
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
WO2019074988A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company A method of treating hair or skin with a personal care composition in a foam form
WO2019074993A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company Sulfate free clear personal cleansing composition comprising low inorganic salt
WO2019074989A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company Compact shampoo composition containing sulfate-free surfactants
JP2020536876A (en) 2017-10-10 2020-12-17 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ Compact shampoo composition containing amino acid-based anionic surfactant and cationic polymer
MX391195B (en) 2017-12-20 2025-03-21 Procter & Gamble Clear shampoo composition containing silicone polymers
EP3813774A1 (en) 2018-06-29 2021-05-05 The Procter & Gamble Company Low surfactant aerosol antidandruff composition
US12226505B2 (en) 2018-10-25 2025-02-18 The Procter & Gamble Company Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents
WO2021113583A1 (en) 2019-12-06 2021-06-10 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
CN115151310B (en) 2020-02-27 2024-12-20 宝洁公司 Sulfur-containing anti-dandruff compositions with enhanced efficacy and aesthetics
EP4247321A1 (en) 2020-11-23 2023-09-27 The Procter & Gamble Company Personal care compositions free of sulfated surfactants
EP4255375B1 (en) 2020-12-04 2025-08-13 The Procter & Gamble Company Hair care composition comprising malodor reduction materials
US12409125B2 (en) 2021-05-14 2025-09-09 The Procter & Gamble Company Shampoo compositions containing a sulfate-free surfactant system and sclerotium gum thickener
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
EP4444431A1 (en) 2021-12-09 2024-10-16 The Procter & Gamble Company Sulfate free personal cleansing composition comprising effective preservation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106106A0 (en) * 1993-06-22 1993-10-20 Interpharm Lab Ltd Library of polymeric molecules and its preparation
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
AU751034B2 (en) * 1998-08-28 2002-08-08 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof

Also Published As

Publication number Publication date
JP4528443B2 (en) 2010-08-18
PL204359B1 (en) 2010-01-29
AU751034B2 (en) 2002-08-08
CZ2001655A3 (en) 2001-11-14
IL141586A0 (en) 2002-03-10
EP1105420A1 (en) 2001-06-13
CN1324367A (en) 2001-11-28
BR9913490A (en) 2001-09-25
KR20010079695A (en) 2001-08-22
WO2000012553A1 (en) 2000-03-09
CA2341810A1 (en) 2000-03-09
HUP0103265A3 (en) 2002-09-30
JP2002523518A (en) 2002-07-30
HUP0103265A2 (en) 2002-02-28
ZA200102489B (en) 2002-06-04
AU5690599A (en) 2000-03-21
JP2010150272A (en) 2010-07-08

Similar Documents

Publication Publication Date Title
PL346346A1 (en) Cyclic prosaposin-derived peptides and uses thereof
PL348648A1 (en) Cyclic tetrapeptide compound and use thereof
EP1064022A4 (en) Hla-binding peptides and their uses
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
PL344341A1 (en) Peptides
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB9806806D0 (en) Peptides and uses thereof
EP0933422A4 (en) Cyclic lipopeptide acylase
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
IL125908A0 (en) Peptides and pharmaceutical compositions comprising same
GB9718110D0 (en) Peptides
EP0970965A4 (en) Cyclic peptides and medicinal use thereof
GB9918155D0 (en) Proteins and peptides
GB9700154D0 (en) Peptides
GB9812675D0 (en) Peptides
GB9714276D0 (en) Peptides and related compounds
EP1080185A4 (en) Myelin basic protein peptides and uses thereof
GR3035848T3 (en) Cyclic peptide derivatives
IL138477A0 (en) Cyclic aminoguanidines
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
PL341293A1 (en) Beta-lypothropin and application thereof
SG74707A1 (en) Cyclic bis-phosphites and compositions
HK1039621A (en) Cyclic prosaposin-derived peptides and uses thereof
EP1132472A4 (en) Novel protein and utilization thereof
EP1067140A4 (en) Novel hemolytic active proteins and genes encoding the same

Legal Events

Date Code Title Description
RECP Rectifications of patent specification
VDSO Invalidation of derivated patent or utility model

Ref document number: 384787

Country of ref document: PL

Kind code of ref document: A1

LAPS Decisions on the lapse of the protection rights

Effective date: 20130820